Literature DB >> 17404331

The treatment of enteric fever.

Buddha Basnyat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17404331      PMCID： PMC1847736          DOI： 10.1258/jrsm.100.4.161

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  10 in total

Review 1.  Typhoid fever.

Authors:  Christopher M Parry; Tran Tinh Hien; Gordon Dougan; Nicholas J White; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

2.  The global burden of typhoid fever.

Authors:  John A Crump; Stephen P Luby; Eric D Mintz
Journal:  Bull World Health Organ       Date:  2004-05       Impact factor: 9.408

Review 3.  Enteric (typhoid) fever in travelers.

Authors:  Buddha Basnyat; Ashish P Maskey; Mark D Zimmerman; David R Murdoch
Journal:  Clin Infect Dis       Date:  2005-09-28       Impact factor: 9.079

4.  Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.

Authors:  Christopher M Parry; Vo Anh Ho; Le Thi Phuong; Phan Van Be Bay; Mai Ngoc Lanh; Le Thanh Tung; Nguyen Thi Hong Tham; John Wain; Tran Tinh Hien; Jeremy J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

5.  Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group.

Authors:  T Lu; X Zhao; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 6.  Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management.

Authors:  T Butler; J Knight; S K Nath; P Speelman; S K Roy; M A Azad
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

7.  Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.

Authors:  Ashish P Maskey; Jeremy N Day; Quoc Tuan Phung; Guy E Thwaites; James I Campbell; Mark Zimmerman; Jeremy J Farrar; Buddha Basnyat
Journal:  Clin Infect Dis       Date:  2006-03-29       Impact factor: 9.079

8.  Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone.

Authors:  S L Hoffman; N H Punjabi; S Kumala; M A Moechtar; S P Pulungsih; A R Rivai; R C Rockhill; T E Woodward; A A Loedin
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

9.  Robust Salmonella metabolism limits possibilities for new antimicrobials.

Authors:  Daniel Becker; Matthias Selbach; Claudia Rollenhagen; Matthias Ballmaier; Thomas F Meyer; Matthias Mann; Dirk Bumann
Journal:  Nature       Date:  2006-03-16       Impact factor: 49.962

10.  Outpatient gatifloxacin therapy and dysglycemia in older adults.

Authors:  Laura Y Park-Wyllie; David N Juurlink; Alexander Kopp; Baiju R Shah; Therese A Stukel; Carmine Stumpo; Linda Dresser; Donald E Low; Muhammad M Mamdani
Journal:  N Engl J Med       Date:  2006-03-01       Impact factor: 91.245
  10 in total
  2 in total

1.  A Biohistorical Perspective of Typhoid and Antimicrobial Resistance.

Authors:  Claas Kirchhelle; Zoe Anne Dyson; Gordon Dougan
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

2.  Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management.

Authors:  Balaji Veeraraghavan; Agila K Pragasam; Pallab Ray; Arti Kapil; Savitha Nagaraj; Sulochana Putli Bai Perumal; Karnika Saigal; Maria Thomas; Madhu Gupta; Temsunaro Rongsen-Chandola; Dasaratha Ramaiah Jinka; Jayanthi Shastri; Anna P Alexander; Roshine Mary Koshy; Anuradha De; Ashita Singh; Sheena Evelyn Ebenezer; Shanta Dutta; Ashish Bavdekar; Deepak More; Sonali Sanghavi; Raghuprakash Reddy Nayakanti; Jobin J Jacob; Anushree Amladi; Shalini Anandan; Baby S Abirami; Yamuna D Bakthavatchalam; Dhiviya P M Sethuvel; Jacob John; Gagandeep Kang
Journal:  J Infect Dis       Date:  2021-11-23       Impact factor: 5.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.